TORONTO, ONTARIO--(Marketwired - June 1, 2017) - The common shares of Supreme Pharmaceuticals Inc. will be delisted at the market close, June 5, 2017.

Supreme Pharmaceuticals will continue to trade on the TSX Venture Exchange.

Date: Market close, June 5, 2017

Symbol: SL

Contact Information:

Canadian Securities Exchange (CSE)
Listings
(416) 367-7340
Listings@thecse.com
www.thecse.com